Thymidine Kinase 2 Deficiency: From Diagnostic Odyssey to Timely Diagnosis and Treatment

To participate in this activity, please:

Mary Kay Koenig, MD, a leader in the management of patients with mitochondrial diseases, delves into the complexities of managing patients with thymidine kinase 2 deficiency (TK2d). In this 1-hour activity, Dr. Koenig shares her insights in the clinical presentation of TK2d through real case studies and offers guidance on overcoming the ‘diagnostic odyssey’ experienced by many patients with mitochondrial disease. She also discusses the clinical criteria for referring patients to specialized mitochondrial treatment centers and explores vital aspects of supportive care. Furthermore, Dr. Koenig also reviews a novel therapy for TK2d currently in clinical trials.

Course Credit:

1.00 AMA PRA Category 1 CreditTM

Dates:

Opens: 2023-10-24
Closes: 2024-10-24

Target Audience:

The education is developed to support neuromuscular specialists and neurologists, pediatricians, primary care providers, pulmonologists, and other specialists who may evaluate symptoms in patients with TK2d.

Supported by an independent educational grant from UCB Pharma.

    Presenting Faculty

  • Mary Kay Koenig, MD

    Professor and Associate Vice-Chair for Clinical Research
    Endowed Chair of Mitochondrial Medicine
    Director, Center for the Treatment of Pediatric Neurodegenerative Disease
    Co-Director, Tuberous Sclerosis Center
    Department of Pediatrics, Division of Child and Adolescent Neurology
    University of Texas Health Science Center at Houston
    UTHealth McGovern Medical School
    Houston, Texas